Brian Kidd - 16 May 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
SVP, CFO
Signature
/s/ Brian F. Kidd
Issuer symbol
NHC
Transactions as of
16 May 2025
Transactions value $
-$54,529
Form type
4
Filing time
20 May 2025, 17:50:32 UTC
Previous filing
05 Mar 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIDD BRIAN F SVP, CFO 100 VINE STREET, MURFREESBORO /s/ Brian F. Kidd 20 May 2025 0001693922

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise $239K +3.73K +16.46% $63.96 26.4K 16 May 2025 Direct F1
transaction NHC Common Stock Tax liability -$293K -2.7K -10.23% $108.61 23.7K 16 May 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -3.73K -100% $0.00 0 16 May 2025 Common Stock 3.73K $63.96 Direct F4
holding NHC Option to Purchase Common Stock 8K 16 May 2025 Common Stock 8K $53.94 Direct
holding NHC Option to Purchase Common Stock 12K 16 May 2025 Common Stock 12K $94.10 Direct
holding NHC Option to Purchase Common Stock 13.5K 16 May 2025 Common Stock 13.5K $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F3 Total amount of shares beneficially owned following transactions reported on this form.
F4 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).